News
Top Big Cap Negative News Movers Premarket: CLDX: -8% Positive Results from Phase 3 EMBARQ-CSU1 and EMBARQ-CSU2 Studies of Barzolvolimab DGX: -6% F
Sep 22, 2026 · ThinkSabio Blog
Top Big Cap Negative News Movers Premarket:
CLDX: -8% Positive Results from Phase 3 EMBARQ-CSU1 and EMBARQ-CSU2 Studies of Barzolvolimab
DGX: -6% Following new CMS Medicare payment talk on lab services
ERIC: -4.5% Downgraded to UNDERWEIGHT @ MS
22-SEP-2026 08:10 AM ET
Share this post
💬 Comments
Loading comments…
Leave a comment
